Return to homepagePandemic Pact

IVIG production from convalescent plasma of COVID-19 survivors: a low risk, high efficiency passive immunization strategy against SARS-CoV-2

  • Funded by Higher Education Commission Pakistan
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Higher Education Commission Pakistan

  • Research Location

    Pakistan

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

To demonstrate the feasibility of the modified caprylic acid method for C-IVIG production from pooled convalescent plasma (PCP) of COVID-19 recovered individuals. Toinvestigate the safety and clinical efficacy of passive immunization therapy through Hyperimmune anti-COVID-19 Intravenous Immunoglobulin (C-IVIG: 5% liquid formulation), on severe and critically ill COVID-19 patients.